Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Atherosclerosis Reports

Issue 1/2010

Content (13 Articles)

Clinical Trial Report

New Evidence Extending the Benefit of Treating LDL-C Beyond the Current Guidelines

Michael Clearfield

Clinical Trial Report

Rosuvastatin and Clinical Outcomes in Individuals Who are not Deemed Appropriate for Baseline Statin Therapy

Michael Clearfield

Clinical Trial Report

Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention

Michael Clearfield

Clinical Trial Report

Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients

William B. Borden

Statin Effects on Both Low-Density Lipoproteins and High-Density Lipoproteins: Is There a Dual Benefit?

Kiyoko Uno, Stephen J. Nicholls

Hypercholesterolemia in Youth: Opportunities and Obstacles to Prevent Premature Atherosclerotic Cardiovascular Disease

Catherine J. McNeal, Tala Dajani, Don Wilson, Andrea E. Cassidy-Bushrow, Justin B. Dickerson, Marcia Ory

Lp-PLA2: A New Target for Statin Therapy

Lynne T. Braun, Michael H. Davidson

Therapeutic Options to Further Lower C-Reactive Protein for Patients on Statin Treatment

Parag H. Joshi, Terry A. Jacobson

Recent Developments with Lipoprotein-Associated Phospholipase A2 Inhibitors

Ryan J. Chauffe, Robert L. Wilensky, Emile R. Mohler III

Management of the Patient with Statin Intolerance

Byron F. Vandenberg, Jennifer Robinson

Development of Apolipoprotein B Antisense Molecules as a Therapy for Hyperlipidemia

Tiffany Thomas, Henry Ginsberg

Fish Oil for Primary and Secondary Prevention of Coronary Heart Disease

Eli M. Roth, William S. Harris

Future Therapeutic Directions in Reverse Cholesterol Transport

Amit V. Khera, Daniel J. Rader

Nov 09
Issue: 6/2009
Mar 10
Issue: 2/2010

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits